Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients

As an adverse survival prognosticator, chemokine (C-X-C motif) ligand 13 (CXCL13) has been studied in several types of malignancies. The secretion and physiological roles of CXCL13 in follicular helper T cells (T(FH)) cells have been well described, while the clinical significance of CD8(+) tumor-in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Jin, Kaifeng, Cao, Yifan, Gu, Yun, Fang, Hanji, Fei, Yuchao, Wang, Jieti, Liu, Xin, Lv, Kunpeng, He, Xudong, Lin, Chao, Liu, Hao, Li, He, He, Hongyong, Li, Ruochen, Zhang, Heng, Xu, Jiejie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8081038/
https://ncbi.nlm.nih.gov/pubmed/33996266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1915560
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia